98.8%
feladilimabanemiaGSK Study 204691
…acokinetic/pharmacodynamic (PK/PD) analysis of the ICOS agonist feladilimab (GSK3359609) as monotherapy. For these cohorts, the objectives …
2articles mentioning drugs
6drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: feladilimab ×
feladilimab
This drug is selected. Its supporting articles are shown below.
Articles mentioning feladilimab
2 articles · page 1 of 1feladilimabvopratelimabICOSJTX-2011GSK3359609
…oritized biological activity over toxicity thresholds. Although feladilimab demonstrated favorable safety and robust receptor occupancy, cl…